Table 6.
Use of contraceptives at the women’s latest intercourse before and after the intervention.
| Before |
After |
||||
|---|---|---|---|---|---|
| IG | CG | IG | CG | ||
| n (%) | n (%) | n (%) | n (%) | P | |
| Combined hormonal contraceptive pill | 240 (40.7) | 234 (38.9) | 241 (40.7) | 239 (39.4) | 0.654 |
| Condom | 113 (19.2) | 100 (16.6) | 68 (11.5) | 59 (9.7) | 0.325 |
| Long-acting reversible contraception | 128 (21.6) | 122 (20.1) | 167 (28.2) | 159 (26.2) | 0.443 |
| Hormonal intrauterine device | 39 (6.6) | 35 (5.8) | 88 (14.9) | 78 (12.9) | 0.318 |
| Copper intrauterine device | 40 (6.8) | 40 (6.7) | 37 (6.3) | 39 (6.4) | 0.895 |
| Progestin implant | 49 (8.3) | 47 (7.8) | 42 (7.1) | 42 (6.9) | 0.912 |
| Combined hormonal contraceptive ring | 34 (5.8) | 41 (6.8) | 41 (6.9) | 53 (8.7) | 0.241 |
| Progestin-only pill | 26 (4.4) | 39 (6.5) | 33 (5.6) | 40 (6.6) | 0.458 |
| Progestin-only injection | 7 (1.2) | 3 (0.5) | 13 (2.2) | 6 (1.0) | 0.095 |
| Other | 5 (0.8) | 11 (1.8) | 11 (1.9) | 17 (2.8) | 0.278 |
| No method | 67 (11.4) | 69 (11.4) | 45 (7.6) | 56 (9.2) | 0.307 |
P values are analyzed after the intervention.